Fingerprint
Dive into the research topics of 'A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically